Savant Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.26M | Buy |
38,763
+15,420
| +66% | +$1.24M | 0.01% | 500 |
|
|
2026
Q1 | $2.02M | Buy |
23,343
+1,458
| +7% | +$140K | 0.01% | 420 |
|
|
2025
Q4 | $2.1M | Buy |
21,885
+3,279
| +18% | +$319K | 0.01% | 399 |
|
|
2025
Q3 | $1.77M | Buy |
18,606
+5,588
| +43% | +$514K | 0.01% | 417 |
|
|
2025
Q2 | $1.13M | Buy |
13,018
+1,437
| +12% | +$122K | 0.01% | 485 |
|
|
2025
Q1 | $1.04M | Sell |
11,581
-78,063
| -87% | -$6.99M | 0.01% | 463 |
|
|
2024
Q4 | $7.16M | Buy |
89,644
+51,985
| +138% | +$4.5M | 0.06% | 192 |
|
|
2024
Q3 | $3.39M | Sell |
37,659
-5,366
| -12% | -$451K | 0.03% | 293 |
|
|
2024
Q2 | $3.39M | Sell |
43,025
-7,363
| -15% | -$604K | 0.03% | 255 |
|
|
2024
Q1 | $4.39M | Buy |
50,388
+17,592
| +54% | +$1.5M | 0.05% | 198 |
|
|
2023
Q4 | $2.7M | Sell |
32,796
-217
| -0.7% | -$16.5K | 0.03% | 239 |
|
|
2023
Q3 | $2.59M | Buy |
33,013
+120
| +0.4% | +$10K | 0.04% | 232 |
|
|
2023
Q2 | $2.9M | Buy |
32,893
+26,305
| +399% | +$2.26M | 0.05% | 218 |
|
|
2023
Q1 | $531K | Buy |
6,588
+2,004
| +44% | +$163K | 0.01% | 450 |
|
|
2022
Q4 | $334K | Buy |
4,584
+272
| +6% | +$22K | 0.01% | 436 |
|
|
2022
Q3 | $348K | Sell |
4,312
-757
| -15% | -$68K | 0.01% | 402 |
|
|
2022
Q2 | $455K | Sell |
5,069
-52
| -1% | -$5.27K | 0.01% | 356 |
|
|
2022
Q1 | $568K | Sell |
5,121
-195
| -4% | -$20.6K | 0.02% | 335 |
|
|
2021
Q4 | $550K | Buy |
5,316
+1,102
| +26% | +$128K | 0.02% | 337 |
|
|
2021
Q3 | $528K | Buy |
4,214
+747
| +22% | +$96.7K | 0.02% | 315 |
|
|
2021
Q2 | $430K | Buy |
3,467
+7
| +0.2% | +$879 | 0.02% | 335 |
|
|
2021
Q1 | $409K | Buy |
3,460
+64
| +2% | +$7.5K | 0.02% | 313 |
|
|
2020
Q4 | $398K | Buy |
3,396
+245
| +8% | +$27K | 0.02% | 309 |
|
|
2020
Q3 | $327K | Sell |
3,151
-101
| -3% | -$10.1K | 0.02% | 322 |
|
|
2020
Q2 | $298K | Buy |
3,252
+29
| +0.9% | +$2.78K | 0.02% | 325 |
|
|
2020
Q1 | $291K | Buy |
3,223
+405
| +14% | +$43.1K | 0.03% | 292 |
|
|
2019
Q4 | $320K | Buy |
2,818
+155
| +6% | +$17K | 0.04% | 274 |
|
|
2019
Q3 | $289K | Buy |
2,663
+211
| +9% | +$22K | 0.04% | 268 |
|
|
2019
Q2 | $239K | Buy |
2,452
+178
| +8% | +$16.3K | 0.03% | 298 |
|
|
2019
Q1 | $207K | Buy |
+2,274
| New | +$204K | 0.04% | 269 |
|
|
2018
Q4 | – | Sell |
-2,174
| Closed | -$214K | – | 281 |
|
|
2018
Q3 | $214K | Sell |
2,174
-202
| -9% | -$18.7K | 0.04% | 278 |
|
|
2018
Q2 | $203K | Buy |
+2,376
| New | +$198K | 0.04% | 274 |
|
|
2015
Q1 | – | Sell |
-3,712
| Closed | -$268K | – | 212 |
|
|
2014
Q4 | $268K | Hold |
3,712
| – | – | 0.1% | 174 |
|
|
2014
Q3 | $230K | Sell |
3,712
-101
| -3% | -$6.42K | 0.1% | 180 |
|
|
2014
Q2 | $243K | Buy |
3,813
+81
| +2% | +$4.92K | 0.11% | 162 |
|
|
2014
Q1 | $230K | Buy |
3,732
+217
| +6% | +$12.6K | 0.11% | 159 |
|
|
2013
Q4 | $202K | Buy |
+3,515
| New | +$199K | 0.1% | 163 |
|
Other funds holding MDT
Savant Capital's MDT Position: Q2 2026 in Review
Savant Capital increased its Medtronic (MDT) stake by 66% in Q2 2026, buying an estimated $1.24M and bringing the position to 38,763 shares worth $3.26M. The position accounts for 0.01% of the portfolio, ranked #500.
Savant Capital first reported a position in MDT in Q4 2013 and has held it in 37 quarters since. The position peaked at $7.16M in Q4 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Savant Capital held 38,763 shares of Medtronic worth $3.26M as of Q2 2026.
- Savant Capital bought 15,420 Medtronic shares in Q2 2026, an estimated $1.24M.
- Medtronic made up 0.01% of Savant Capital's portfolio in Q2 2026, its #500 holding.
- Savant Capital first reported a position in Medtronic in Q4 2013 and has held it in 37 quarters since.
- Savant Capital's Medtronic position peaked at $7.16M in Q4 2024.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.